HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals.

Abstract
Recently, several neutralizing anti-HIV antibodies have been isolated from memory B cells of HIV-infected individuals. Despite extensive evidence of B cell dysfunction in HIV disease, little is known about the cells from which these rare HIV-specific antibodies originate. Accordingly, we used HIV envelope gp140 and CD4 or coreceptor (CoR) binding site (bs) mutant probes to evaluate HIV-specific responses in peripheral blood B cells of HIV-infected individuals at various stages of infection. In contrast to non-HIV responses, HIV-specific responses against gp140 were enriched within abnormal B cells, namely activated and exhausted memory subsets, which are largely absent in the blood of uninfected individuals. Responses against the CoRbs, which is a poorly neutralizing epitope, arose early, whereas those against the well-characterized neutralizing epitope CD4bs were delayed and infrequent. Enrichment of the HIV-specific response within resting memory B cells, the predominant subset in uninfected individuals, did occur in certain infected individuals who maintained low levels of plasma viremia and immune activation with or without antiretroviral therapy. The distribution of HIV-specific responses among memory B cell subsets was corroborated by transcriptional analyses. Taken together, our findings provide valuable insight into virus-specific B cell responses in HIV infection and demonstrate that memory B cell abnormalities may contribute to the ineffectiveness of the antibody response in infected individuals.
AuthorsLela Kardava, Susan Moir, Naisha Shah, Wei Wang, Richard Wilson, Clarisa M Buckner, Brian H Santich, Leo J Y Kim, Emily E Spurlin, Amy K Nelson, Adam K Wheatley, Christopher J Harvey, Adrian B McDermott, Kai W Wucherpfennig, Tae-Wook Chun, John S Tsang, Yuxing Li, Anthony S Fauci
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 124 Issue 7 Pg. 3252-62 (Jul 2014) ISSN: 1558-8238 [Electronic] United States
PMID24892810 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural)
Chemical References
  • Anti-HIV Agents
  • Antibodies, Neutralizing
  • HIV Antibodies
  • HIV Envelope Protein gp120
  • env Gene Products, Human Immunodeficiency Virus
  • gp140 envelope protein, Human immunodeficiency virus 1
Topics
  • Acute Disease
  • Anti-HIV Agents (therapeutic use)
  • Antibodies, Neutralizing (blood)
  • B-Lymphocyte Subsets (immunology, metabolism, pathology)
  • Chronic Disease
  • HIV Antibodies (blood)
  • HIV Envelope Protein gp120 (immunology)
  • HIV Infections (genetics, immunology, virology)
  • Humans
  • Immunologic Memory
  • Transcriptome
  • Viral Load
  • env Gene Products, Human Immunodeficiency Virus (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: